IPAR at a glance
INTERPARFUMS INC (IPAR, SEC CIK 822663) filed its latest 10-K annual report on March 10, 2026, a 10-Q quarterly report on August 4, 2026, an 8-K current report on September 22, 2026 and Form 4 insider filings as recently as August 27, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), INTERPARFUMS INC (IPAR) reported revenue of $1.5 billion (up 2.5% from FY2024) and net income of $168.4 million. Diluted EPS was $5.24.
- As of June 30, 2026, 34 institutional investment managers tracked by SignalX reported holding INTERPARFUMS INC (IPAR) shares worth $1.3 billion in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Gabai-Pinsky Veronique on August 27, 2026 of 900 shares at $116.86 per share.
- In the last 90 days, IPAR insiders reported 0 open-market purchases ($0) and 1 open-market sale ($105K) on Form 4, a net sale of $105K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $1.5B
- +2.5% vs prior year
- Insiders · 90 days
- 0 buys · 1 sell
- Net −$105K
- 13F holders
- 34 funds
- $1.3B · +0 vs prior quarter
- Latest 8-K
- Sep 22, 2026
- Item 8.01
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Core business model centered on fragrance creation, manufacturing, and distribution globally
- Emphasis on strengthened cybersecurity operations with dedicated IT departments in U.S. and Europe managing network security and incident prevention
- New IT Charter and mandatory cybersecurity training initiated January 2024 for all Interparfums SA employees
- No material cybersecurity incidents reported as of filing date, indicating effective risk mitigation
- Implementation of daily data backups, two-factor authentication, and quarterly password updates across workforce
Management Discussion & Analysis
- Foreign currency forward contracts $64M notional, mature within one year, used to hedge receivables and forecasted sales
- Derivatives recorded at fair value, gains/losses recognized in earnings or other comprehensive income if cash flow hedge
- Hedge effectiveness measured continuously, any ineffectiveness recognized in income statement
- No trading in foreign currency forwards or interest rate swaps; risk of counterparty nonperformance considered remote
- Interest rate risk managed by monitoring rates and swapping fixed/floating debt as needed
AI summary of the IPAR 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Revenue $341.0M, up 2% YoY; U.S. sales $112.8M, up 18%, offset European sales down 4%
- Operating margin 14.4% vs 17.7% YoY; gross margin 65.5% vs 66.2%
- Best performer Ferragamo, sales up 41%; weakest Lacoste, sales down 19%
- Cash, equivalents and short-term investments $211.3M at June 30, 2026
- Outlook optimistic for remainder of 2026; Middle East war headwind of 3%, tariffs and Eastern Europe challenges emerging risks
Risk Factors
- No material risk-factor changes disclosed; 2025 Form 10-K remains the referenced source
- Share-repurchase funding risk from newly authorized line of credit up to $250 million, with terms still unsettled
- Capital-allocation uncertainty from potential purchases of Interparfums, Inc. or 72%-owned Interparfums SA shares
- Execution risk: company cannot assure completion of the repurchase program or any minimum shares repurchased
AI summary of the IPAR 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 8.01: Other Events
- September 22, 2026 press release furnished as Exhibit 99.1
- Investor-relevant event details reside in the referenced press release
Item EX-99.1: Item EX-99.1
- Exclusive worldwide PUMA fragrance license, extending through December 31, 2037
- New PUMA signature lifestyle fragrance planned for launch in 2027
Item EX-99.1: Item EX-99.1
- Exclusive worldwide Roberto Cavalli and Just Cavalli fragrance license extended 20 years through December 31, 2046
- Long-term renewal secures strategic portfolio rights and supports sustained fragrance development across global markets
Item 8.01: Other Events
- Roberto Cavalli and Just Cavalli license extended through 2046
- Long-term brand access supports Inter Parfums’ portfolio continuity and future product development
Item 5.07: Submission of Matters to a Vote of Security Holders
- All nine director nominees elected for one-year terms, maintaining board continuity
- Benedicte Epinay received strongest support, with 23,797,965 votes for and 29,506 withheld
Item 8.01: Other Events
- Valerie Hermann and Benedicte Epinay elected to Inter Parfums’ board
- Leadership additions potentially strengthening luxury-fragrance industry expertise
Item EX-99.1: Item EX-99.1
- Shareholders approved a nine-member board, with four departures and two new independent directors
- Luxury-sector expertise added through Valérie Hermann and Bénédicte Epinay, strengthening brand, sustainability, and industry oversight
AI summaries of IPAR 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for IPAR
Don't miss the next IPAR filing
- Alerts as it files. A push when IPAR files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut IPAR, by share count.
- Ask anything. An AI agent that reads every IPAR filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Gabai-Pinsky Veronique | M | Aug 27, 2026 | 300 | - |
| Gabai-Pinsky Veronique | M | Aug 27, 2026 | 300 | - |
| Gabai-Pinsky Veronique | M | Aug 27, 2026 | 300 | - |
| Gabai-Pinsky Veronique | M | Aug 27, 2026 | 900 | $97.84 |
| Gabai-Pinsky Veronique | Sell | Aug 27, 2026 | 900 | $116.86 |
| HEILBRONN FRANCOIS | M | Jan 23, 2026 | 375 | - |
| HEILBRONN FRANCOIS | M | Jan 23, 2026 | 375 | - |
| HEILBRONN FRANCOIS | M | Jan 23, 2026 | 1,500 | $62.18 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $1.5B | $1.5B |
| Gross Profit | - | $927.3M | $947.2M |
| Operating Income | - | $274.8M | $270.3M |
| Net Income | - | $164.4M | $168.4M |
| Gross Margin | - | 63.9% | 63.6% |
| Op. Margin | - | 18.9% | 18.2% |
| Net Margin | - | 11.3% | 11.3% |
| Balance Sheet | |||
| Total Assets | $1.4B | $1.4B | $1.6B |
| Equity | $699.4M | $744.9M | $880.7M |
| ROE | - | 22.1% | 19.1% |
| Per Share | |||
| EPS | - | $5.12 | $5.24 |
| Cash Flow | |||
| Operating CF | - | $187.6M | $214.9M |
| CapEx | - | $4.7M | $24.4M |
Source: XBRL data in INTERPARFUMS INC (IPAR)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate IPAR share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 34 | $1.34B |
| Q1 2026 | 34 | $1.04B |
| Q4 2025 | 32 | $970.7M |
| Q3 2025 | 33 | $1.13B |
| Q2 2025 | 31 | $1.37B |
| Q1 2025 | 27 | $797.0M |
| Q4 2024 | 25 | $753.6M |
| Q3 2024 | 21 | $392.5M |
- BlackRock+182.2K (+7%)
- Two Sigma Investments+141.9K (+471%)
- Goldman Sachs Group+139.1K (+79%)
- T. Rowe Price Group+84.4K (+40%)
- Dimensional Fund Advisors+70.4K (+9%)
- Ameriprise Financial−124.7K (-73%)
- WESTWOOD HOLDINGS GROUP INC−119.5K (-12%)
- Millennium Management−76.3K (-86%)
- AQR Capital Management−37.2K (-21%)
- Citadel Advisors LLC−22.5K (-85%)
Source: 13F-HR filings on SEC EDGAR (aggregated from 237 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
IPAR filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Sep 22, 2026 | - | Analysis | - |
| 8-K | Sep 17, 2026 | - | Analysis | - |
| 8-K | Sep 16, 2026 | - | Analysis | - |
| 4 | Aug 27, 2026 | - | - | - |
| 8-K | Aug 4, 2026 | - | Analysis | - |
| 10-Q | Aug 4, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Jul 22, 2026 | - | Analysis | - |
| 8-K | May 13, 2026 | - | Analysis | |
| 10-Q | May 5, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | May 5, 2026 | - | Analysis | - |
| 8-K | Apr 21, 2026 | - | Analysis | - |
| 10-K | Mar 10, 2026 | Dec 31, 2025 | Analysis | |
| 8-K | Feb 24, 2026 | - | Analysis | - |
| 8-K | Jan 29, 2026 | - | - | |
| 8-K | Jan 29, 2026 | - | - | |
| 4 | Jan 26, 2026 | - | - | |
| 8-K | Jan 26, 2026 | - | - | |
| 4 | Jan 23, 2026 | - | - | |
| 4 | Jan 23, 2026 | - | - | |
| 8-K | Jan 21, 2026 | - | - | |
| 4 | Jan 5, 2026 | - | - | |
| 4 | Jan 5, 2026 | - | - | |
| 4 | Jan 5, 2026 | - | - | |
| 4 | Jan 5, 2026 | - | - | |
| 4 | Jan 5, 2026 | - | - |
Related Consumer Staples companies
- CL · Colgate-PalmolivePerfumes, Cosmetics & Other Toilet Preparations
- EPC · EDGEWELL PERSONAL CARE CoPerfumes, Cosmetics & Other Toilet Preparations
- EL · Estée Lauder Companies (The)Perfumes, Cosmetics & Other Toilet Preparations
- KVUE · KenvuePerfumes, Cosmetics & Other Toilet Preparations
- OLPX · OLAPLEX HOLDINGS, INC.Perfumes, Cosmetics & Other Toilet Preparations
- SLSN · SOLESENCE, INC.Perfumes, Cosmetics & Other Toilet Preparations
- WALD · Waldencast plcPerfumes, Cosmetics & Other Toilet Preparations
- ACI · Albertsons Companies IncRetail-Grocery Stores
IPAR SEC filings: frequently asked questions
Are IPAR insiders buying or selling?
In the last 90 days, INTERPARFUMS INC (IPAR) officers, directors and 10% owners reported no open-market purchases and 1 open-market sale worth $105,173 by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold IPAR stock?
As of June 30, 2026, the largest INTERPARFUMS INC (IPAR) holders among the 13F filers tracked by SignalX were BlackRock ($326.3 million), Morgan Stanley ($149.0 million), Vanguard Portfolio Management LLC ($146.1 million), WESTWOOD HOLDINGS GROUP INC ($99.1 million), Dimensional Fund Advisors ($96.9 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was IPAR's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), INTERPARFUMS INC (IPAR) reported revenue of $1.5 billion (up 2.5% from FY2024) and net income of $168.4 million. Diluted EPS was $5.24. The figures come from the XBRL data in the 10-K.
What did IPAR report in its latest 8-K?
INTERPARFUMS INC (IPAR) filed an 8-K on September 22, 2026 reporting Item 8.01 (Other Events). September 22, 2026 press release furnished as Exhibit 99.1.
What are the latest IPAR SEC filings?
INTERPARFUMS INC (IPAR) filed its latest 10-K annual report on March 10, 2026, a 10-Q quarterly report on August 4, 2026, an 8-K current report on September 22, 2026 and a Form 4 insider filing on August 27, 2026.
What is IPAR's SEC CIK number?
INTERPARFUMS INC (IPAR)'s SEC Central Index Key (CIK) is 822663. EDGAR lists every IPAR filing under that number.
Ask anything about IPAR
The research agent reads IPAR's filings, financials, insider trades and 13F holders, then answers with sources.